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ABSTRACT 
Purpose: The aim of this study was to describe the relationship between body size and the 
oxygen uptake efficiency slope (OUES) in paediatric patients with cystic fibrosis (CF) and 
healthy controls (CON), in order to identify appropriate scaling procedures to adjust the 
influence of body size upon OUES. Methods: The OUES was derived using maximal and 
submaximal points from cardiopulmonary exercise testing in 72 children (36 CF and 36 CON). 
OUES was subsequently scaled for stature, body mass (BM) and body surface area (BSA) using 
ratio-standard (Y/X) and allometric (Y/X
b
) methods. Pearson’s correlation coefficients were 
utilised to determine the relationship between body size and the OUES. Results: When scaled 
using the ratio-standard method, OUES had a significant positive relationship with stature (r = 
0.54, P < 0.001) and BSA (r = 0.25, P = 0.031) and significant negative relationship with BM (r 
= -0.38, P = 0.016) in the CF group. Combined allometric exponents (b) for CF and CON were: 
stature 3.00, BM 0.86, BSA 1.40. A significant negative correlation was found between OUES 
and stature in the CF group when scaled allometrically (r = -0.37, P = 0.027). Non-significant (P 
> 0.05) correlations for the whole group were found between OUES and allometrically scaled 
BM (CF: r = -0.25, CON: r = 0.15) and BSA (CF r = -0.27, CON r = 0.13). Conclusions: Only 
allometric scaling of either BM or BSA, and not ratio-standard scaling, successfully eliminates 
the influence of body size upon OUES. Therefore this enables a more direct comparison of the 
oxygen uptake slope between patients with CF and healthy controls.  
 
Keywords: exercise capacity, modelling, adolescence, respiratory, pulmonary disease  
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INTRODUCTION 
It has been established that a high cardiopulmonary fitness (as represented by maximal oxygen 
uptake [V O2max]) is of benefit to young patients with cystic fibrosis (CF), being associated with 
an increased quality of life (22) and reduced risk of hospitalisation (27) and mortality (28). As 
such, regular, maximal, exercise testing is recommended to provide clinically relevant prognostic 
information for clinicians and patients (14), with cardiopulmonary exercise testing (CPET) 
endorsed as method of choice by the European Cystic Fibrosis Society and European Respiratory 
Society (21). However, measuring V  2max, by definition, requires a maximal effort and some 
patients may be unable or unwilling to reach a volitional maximum. Therefore, the oxygen 
uptake efficiency slope (OUES) (4), a reliable (31) and effort-independent measure of ventilatory 
efficiency, may be a viable submaximal alternative to V  2max in this patient group (18).  
 
Previous research in healthy adults has shown that OUES is strongly related to body size 
variables including stature, body mass (BM) and body surface area (BSA) (12), and has 
subsequently been applied to clinical settings including cardiac (36), neurological (23) and 
respiratory (6) populations, including a single study of adults with CF (18). This strong 
dependency on body size confounds interpretation of OUES and requires the use of scaling 
techniques to ensure appropriate interpretation within and between groups. However, scaling 
procedures have been performed by most (6, 12, 18, 36) but not all (23) studies to date.  
 
The strong positive relationship between OUES and body size has further been observed in 
paediatric studies using stature (25), BM (11) and BSA (1). Whilst such paediatric studies have 
attempted to control for body size (1, 9, 10, 16), it has been assumed that the ratio standard 
scaling method (OUES/body size [Y/X]) is an effective approach at removing the influence of 
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body size. However, there are validity concerns associated with the ratio-scaling procedure that 
have been utilised to date (26). This issue may have greater implications in children (3), whose 
body size is rapidly changing with age, and furthermore in children with CF, who are 
characterised by malnutrition and inadequate growth (13).  
 
Previous research has identified allometric scaling (Y/X
b
, where b represents a power function to 
which X is raised) as a superior technique to the ratio-standard methods for controlling for body 
size when assessing V  2max in both adults (7) and children (17). However, its applicability for 
scaling OUES in contrast to the currently employed ratio standard method remains unknown 
 
Although the use of OUES in children with CF has been proposed (9), there are currently no 
studies that critically examine the validity of scaling methods to adjust for body size. 
Furthermore, the one previous study to have examined the role of OUES in children with CF (9) 
scaled for BSA using a ratio-standard approach. However, the utility of other body size variables 
that are frequently collected by clinical teams (stature, body mass) were not systematically 
considered.  
 
Therefore the aim of this study was twofold: Firstly to characterise the relationship between body 
size and OUES in children with CF; and secondly, to identify the most appropriate procedure 
(ratio standard or allometric) for scaling OUES against different body size variables (stature, BM 
and BSA) in paediatric patients with CF and a matched control (CON) group. It is hypothesised 
that the allometric scaling procedure will remove the residual effects of body size on OUES 
compared to ratio standard procedures.    
  
AC
CE
PT
ED
Copyright © 2017 by the American College of Sports Medicine. Unauthorized reproduction of this article is prohibited.
 
 
 
 
METHODS 
Study Participants. Data were extracted from existing databases of valid CPET data, with 45 
children and adolescents with CF being considered for inclusion in the current analysis. A total 
of 9 participants were excluded due to inadequate data (insufficient, or missing data, n = 7; 
insufficient test length, n = 2), resulting in a final sample of 36 children and adolescents with CF.  
Data were then age- and gender-matched against existing CON CPETs, resulting in a total 
sample of 72 participants (36 CF, 36 CON; mean age 13.3 ± 2.8 years).   
 
For original data collection, ethics approval was granted by institutional and NHS Research 
Ethics committees. Written informed consent and assent were obtained from parents/guardians 
and children respectively.  
 
Experimental Measures. Stature was measured to the nearest 0.01 m using a wall-mounted 
stadiometer (Holtain Ltd., Crymych, UK) and BM to the nearest 0.01 kg using a digital scale 
(Seca, Birmingham, UK). Body surface area (BSA) was estimated using the Haycock equation 
(20). Pulmonary function was assessed using a hand-held spirometer, with values for forced 
expiratory volume in one second (FEV1) and forced vital capacity (FVC) being determined.   
 
Experimental Protocol. All participants undertook an incremental CPET to volitional 
exhaustion on an electronically braked cycle ergometer (Lode, Groningen, the Netherlands). 
Breath-by-breath gas exchange data were collected using an online Cortex gas analysis system 
(Cranlea, Birmingham, UK) and exported in 10-second averages. Within the sample, 33 children 
(20 CF, 13 CON) undertoo  an additional supra axi al verification  out to deter ine V  2max 
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(5, 30). However, as not all children undertook the verification bout the highest V  2 o served is 
descri ed as pea  V  2.  
 
Peak V  2 was obtained from the highest 10-second average from either the ramp or 
supramaximal bout (where applicable) and the gas exchange threshold (GET) was identified 
using the V-slope method (8) and confir ed through visual inspection of ventilatory equivalents 
for V  2 and V C 2. OUES was ascertained at three different intensities (100%, 75% and 50% of 
peak V  2), using data from the whole test up to, and including, the intensity of interest, in line 
with previous research (9). Simple, linear regressions between V O2 (mL
.
min
-1
) and logVE were 
calculated in the form using GraphPad Prism (GraphPad Software, Inc., San Diego, CA, USA):  
 
V O2 = a (logVE) + b   Equation 1 
 
where the constant a the slope is defined as the OUES, and b the intercept with the y-axis (4). 
Regression constants were subsequently produced, as per Figure 1, to allow comparisons 
between groups.  
 
Scaling Approaches. Each body size variable (stature, BM and BSA) was used to scale OUES 
at peak V  2, and at the GET, using the ratio-standard (Y/X) and allometric (Y/Xb) scaling 
methods. Allometric scaling of OUES was performed using log-linear regression models (34) 
with disease status (CF or CON) and the anthropometric variable in question (stature, BM, BSA) 
entered as predictor variables. Age and gender were not entered into the model due to the prior 
matching of patients. The log-linear regression models produced scaling exponents (b) and 
associated 95% confidence intervals (CIs) that were used to scale the OUES using a power 
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function ratio (Y/X
b
). All regression models assumptions (multicollinearity and independence, 
homoscedasticity, linearity and normal distribution of residuals) were checked and satisfied. The 
log-linear regression model was conducted for each group (CF and CON separately) and as a 
combined whole (CF and CON combined) for each OUES parameter (peak V  2, 75% peak V  2, 
50% peak V  2).  
 
Statistical Analyses. Statistical analyses were conducted using SPSS v.23 (IBM, Armonk, NY, 
USA). Independent t-tests identified mean differences in the anthropometric and CPET outcomes 
between CF and CON. Pearson’s correlation coefficients were run to exa ine the relationship 
between each body size variable and the absolute, ratio-standard scaled and allometrically-scaled 
OUES to assess size dependence of OUES. Fisher’s z-transformations identified group 
differences between correlations. The alpha level was set at 0.05 for all analyses.  
 
RESULTS 
All descriptive data are presented as mean and standard deviation. Differences between group 
means with regards to the anthropometric, pulmonary and CPET outcomes are presented in 
Table 1. No significant differences (P > 0.05) were observed between groups for anthropometric 
or CPET variables. A significantly (P < 0.05) lower FEV1 (% predicted) was observed in the CF 
group, but no other pulmonary variables.  
 
Each body size variable was significantly (P < 0.001) and positively correlated with OUES 
(Figure 2; A1, B1, C1).  This finding is consistent across CF, CON, and as a combined group 
(Table 2), with the magnitude of the correlation consistently lower in CF when compared against 
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CON. However, this was only statistically significant (P < 0.05) for absolute OUES when 
plotted against stature (Figure 2; A1).  
 
When the ratio-standard scaling (Y/X) method was used, significant and positive correlations 
were present between the scaled maximal OUES and both stature and BSA for the combined 
group (Table 2) and CON group (Figure 2; A2, C2), but not the CF group. Whilst OUES scaled 
for BM did not retain a significant relationship with BM itself at the combined level (Table 2), it 
approached significance (P = 0.073). When split into sub-groups, a significant negative 
relationship was observed between scaled OUES and BM in CF (Figure 2; B2).  
 
The output from the log-linear regression models is displayed in Table 3. Smaller b exponents 
were observed for the CF group, when compared to CON, for each anthropometric factor. The 
exponents for the combined group were as follows: at 50% peak V  2 (stature = 3.60, BM = 1.06, 
BSA = 1.72); at 75% peak V  2 (stature = 2.93, BM = 0.80, BSA = 1.31), and at 100% peak V  2 
(stature = 2.59, BM = 0.77, BSA = 1.24). A greater difference was evident between the scaling 
exponents (Δb) of CF and CON groups for stature (1.39) relative to those for body mass (0.16) 
and BSA (0.36). When the exponents were averaged across groups and OUES parameters, the 
scaling factors were stature = 3.00, BM = 0.86, and BSA = 1.40.  
 
When OUES was scaled allometrically (Y/X
b
) using the averaged exponents from Table 3, no 
significant correlations were present against BM or BSA at either the group (Figure 2; B3, C3) or 
combined (Table 2) level. However, a significant (P < 0.05) negative relationship was evident 
within the CF group between allometrically-scaled OUES and stature (Figure 2; A3).  
Furthermore, allo etric scaling of  UES at su  axi al intensities (    pea  V  2 and 75% 
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peak V  2), using the exponents identified in Table 3 for BM and BSA produced non-significant 
correlations (P > 0.05; data not reported).   
 
DISCUSSION 
The aims of this study were to initially describe the relationship between OUES and body size in 
children with CF and to identify appropriate procedures for scaling OUES against different body 
size variables. The main results have shown both significant relationships between OUES and 
body size; and that ratio-standard scaling is ineffective in controlling for body size, whereas 
allometric scaling does remove residual influences.  
 
The relationships between body size and OUES for the present study are shown in Table 2 and 
Figure 2. These analyses identified large correlations for the CON group, with the magnitude 
closely resembling previous OUES research in healthy 7-18 year olds (25). No previous study 
has detailed the magnitude of the relationship between OUES and body size in children with CF. 
The magnitude of the correlation in the CF group is lower than the CON group and reached 
statistical significance for the relationship between OUES and stature (Table 2, Figure 2). This 
could be due to the shorter stature typically observed in children with CF (15) – a consequence 
of the chronic malnutrition associated with the disease (13). However, the reported non-
significant difference in body size, including stature, and OUES at peak exercise between CF and 
CON groups is similar to previous studies, despite decreased mean OUES values at peak 
exercise for both CF and CON groups in relation to previous research – a difference potentially 
accounted for by differences in aerobic fitness (9). This suggests additional body size 
independent factors affect the OUES in CF and therefore may account for the smaller correlation 
coefficients observed in the present study.  
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When ratio-standard scaling is utilised to adjust OUES, significant correlations exist against all 
the body size variables (Table 2, Figure 2; A2, B2, C2), with the magnitude, and significance, of 
coefficients being different for each body size variable and group. These significant positive 
coefficients result in biasing against individuals with a smaller stature or BSA. Whilst the 
combined correlation coefficient for BM is non-significant, it remains significant and negative 
within the CF group, thus biasing against heavier individuals, and removing its potential to be 
uniformly utilised across both groups. Furthermore, evidence against the use of the ratio-standard 
method to scale OUES is provided by the b values obtained in the log-linear regression. For the 
ratio-standard method to be effective, the b values would be required to equal, or at least be very 
close to, 1 (33). As is shown in Table 3, the obtained values do not equal 1, nor do the 95% CI, 
which represent the uncertainty of the point estimate, span 1 consistently across both groups. 
Therefore, the ratio-standard procedure does not uniformly control for size in children with, and 
without CF, for each body size variable.  
 
Previous research has advocated scaling of OUES in children using a ratio-standard approach, 
controlling for fat-free mass (FFM) or BSA (1). However, the authors did not verify the 
assumption that this technique appropriately removes the influence of body size. As a result, 
subsequent studies have cited this study as reason for scaling OUES in such a manner when 
making comparisons between groups in paediatric populations with chronic disease (9, 10, 35). 
However, the results of the current study have shown the ratio standard approach to be invalid 
and is likely to result in incorrect conclusions in previous OUES research due to the inaccurate 
expression of data (9).  
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Upon utilising allometric scaling, non-significant relationships (P > 0.05) were found between 
the corrected OUES from peak exercise and both BM and BSA for CF and CON groups, as well 
as the combined group values. However, the magnitude of coefficient is between -0.25 and -0.30 
for BM and BSA in the CF group, indicating that this method does not fully control for size, but 
remains an improvement on the ratio-standard method. Unlike BM and BSA, stature retained a 
significant relationship with allometrically corrected OUES within the CF group (P < 0.05; 
Figure 2; A3). A non-significant mean difference between CF and CON for stature was found, 
therefore suggesting it is not stature itself, but the interaction of the two (stature and OUES) that 
is different between groups. This difference in the relationship between stature and OUES is 
further evidenced by b values between groups (Table 3), with the Δb between CF and CON of 
1.39 being over three times greater than that of BSA (Δb = 0.36). Therefore, our data suggest 
stature is an unsuitable variable for scaling OUES, regardless of which scaling procedure is used. 
In contrast, the more homogenous b values between CF and CON groups for both BM and BSA 
(Table 3) indicate these body size variables should be used for future allometric scaling of 
OUES, as the exponents can be uniformly applied to both groups. The same results were found 
for  UES at su  axi al intensities (    pea  V  2 and     pea  V  2), with allometric scaling 
proving to be the optimal methodology for removing residual effects of body size. This is a 
notable finding, as it highlights the importance of scaling, even for submaximal parameters of 
exercise, given that many patients may be unable, or unwilling, to perform maximal exercise.   
 
The results shown above indicate that either BM or BSA is an appropriate body size variable 
against which to scale OUES, provided an allometric approach is used. However, previous 
research is equivocal on which body size variable to use, with both BM (4, 11, 25, 29) and BSA 
(9-11, 35) being frequently used. BSA has been suggested for use, due to its ability to normalise 
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for pulmonary volume (24). However due to progressive declining of lung function observed in 
individuals with CF (19), it is unclear whether BSA appropriately normalises for pulmonary 
volume, a point further supported by the significant differences in lung function between groups 
in the current study. In addition, whilst BM remains a suitable anthropometric scaling variable, 
ideally, FFM should be used as it better reflects the metabolic cost of exercise (1). However this 
measure is not routinely collected by CF clinics, and body composition data, as estimated from 
skinfold and bioelectrical impedance methods, have poor accuracy at the individual level (2). As 
such, there is no evidence to suggest superiority of either BM or BSA for use in scaling OUES. 
Therefore, the suitability of each anthropometric variable needs to be investigated further to 
ensure future standardisation of research.  
 
Clinicians involved in the management of CF perceive CPET as a useful tool (32), with regular 
exercise testing recommended for individuals with CF (21). Given the clinical importance of 
exercise testing, it is therefore essential that appropriate measures and methodologies are being 
utilised to analyse outcomes. In order to streamline analyses for clinical teams, the b exponent 
values for BM and BSA provided here may be utilised, provided patient characteristics are in 
line with current study. However, the purpose of this study was not to create a universal scaling 
exponent for OUES, as it is likely that scaling exponents may change between patient cohorts, 
and therefore future studies should utilise these described methodologies to derive their own 
exponents to ensure a size-free expression of OUES.  
 
CONCLUSION 
This study has identified that ratio-standard scaling of the OUES is an invalid scaling method 
when using stature, BSA or BM as a significant relationship still exists with body size. In 
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contrast, allometric scaling of BM and BSA was better able to control for body size in young 
people with CF and age and sex matched controls, and should be used in future research 
investigating the clinical utility of OUES in this patient group. Therefore, this study recommends 
that allometrically scaled BM or BSA should be promoted for use in future research and/or 
clinics where OUES is sought as an outcome measure from a CPET.  
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FIGURE LEGENDS 
 
Figure 1. Relationship  etween oxygen upta e (V  2; mL
.
min
-1
) and minute ventilation (VE; 
L
.
min
-1       and V  2 (mL
.
min
-1
) and log10VE (L
.
min
-1
) [2] during incremental exercise in 
representative 13-year old boys – one with CF [A] and one without [B]. Differences in 
ventilation are clear between participants (i.e., linear vs. curvilinear response), however 
normalisation of ventilation through log transformation (thus producing OUES) allows for direct 
comparision between individuals.  
 
Figure 2. Scatter plots with Pearsons correlation coefficients for CF (●, solid line  and C N (○, 
dashed line) groups for OUES from peak exercise when scaled utilising each variable (stature 
[A], body mass [B] and body surface area [C]) and procedure (absolute [1], ratio-standard [2] 
and allometric [3]). * Significant difference (P < 0.05) between the magnitude of the correlation 
coefficients between CF and CON. 
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Figure 2 
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TABLES 
 
Table 1. Anthropometric, pulmonary and exercise-related differences between children with CF 
and age- and gender-matched controls.  
Variable CF CON P Value 
Stature (cm) 155.6 ± 13.6 159.1 ± 15.2 0.32 
Body Mass (kg) 50.15 ± 15.46 51.15 ± 14.49 0.78 
Body Surface Area (m
2
) 1.46 ± 0.28 1.49 ± 0.28 0.65 
FEV1 (L
.
min
-1
)* 2.46 ± 0.97 2.96 ± 0.86 0.07 
FEV1 (% Predicted)* 88.0 ± 19.6 101.9 ± 12.2 0.002 
FVC (L
.
min
-1
)* 3.10 ± 1.14 3.44 ± 1.02 0.30 
FVC (% Predicted)* 94.8 ± 15.9 100.2 ± 12.5 0.21 
Peak V  2 (L
.
min
-1
) 1.74 ± 0.57 2.03 ± 0.88 0.09 
Pea  V  2 (mL
.
kg
-1.
min
-1
) 37.74 ± 7.74 39.93 ± 10.71 0.32 
GET (  pV  2) 53.3 ± 9.3 55.0 ± 8.0 0.42 
Peak Power Output (W) 146 ± 57 175 ± 72 0.06 
 UES (at      pea  V  2) 1927.58 ± 583.49 2148.77 ± 846.55 0.20 
 UES (at     pea  V  2) 1842.81 ± 541.13 2066.11 ± 892.96 0.20 
 UES (at     pea  V  2) 1604.87 ± 661.75 1815.92 ± 852.51 0.27 
Values are presented as mean ± standard deviation. P value, independent samples t-test 
significance level. FEV1, forced expiratory volu e in   second  FVC, forced vital capacity  pea  
V  2, peak oxygen uptake; GET, gas exchange threshold; OUES, oxygen efficiency uptake slope. 
* Unequal groups for pulmonary volumes (CF, n = 36; CON, n = 18).  
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Table 2. Pearson’s correlation coefficients for  UES at pea  V  2 when scaled for body size 
using difering scaling procedures for whole-group (CF + CON) 
 CF CON Combined 
Absolute 
Stature vs. OUES 
 
r = 0.545, P < 0.001 
 
r = 0.800, P < 0.001 
 
r = 0.703, P < 0.001 
Mass vs. OUES r = 0.536, P < 0.001 r = 0.747, P < 0.001 r = 0.640, P < 0.001 
BSA vs. OUES r = 0.578, P < 0.001 r = 0.783, P < 0.001 r = 0.685, P < 0.001 
Ratio Standard 
Stature vs. OUES/Stature
 
 
r = 0.296, P = 0.079 
 
r = 0.704, P < 0.001 
 
r = 0.543, P < 0.001 
Mass vs. OUES/Mass r = -0.379, P = 0.016 r = -0.042, P = 0.806 r = -0.212, P = 0.073 
BSA vs. OUES/BSA r = 0.021, P = 0.905 r = 0.447, P = 0.006 r = 0.254, P = 0.031 
Allometric 
Stature vs. OUES/Stature
3.00
 
 
r = -0.369, P = 0.027 
 
r = 0.111, P = 0.520 
 
r = -0.139, P = 0.245 
Mass vs. OUES/Mass
0.86
 r = -0.253, P = 0.136 r = 0.150, P = 0.383 r = -0.041, P = 0.730 
BSA vs. OUES/BSA
1.40
 r = -0.272, P = 0.108 r = 0.129, P = 0.453 r = -0.062, P = 0.606 
Bold text indicates a significant (P < 0.05) correlation. Bivariate plots are shown in Figure 2.  
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Table 3. Allometric exponents for the OUES measures and body size in young patients with CF 
and healthy age- and gender-matched controls. 
 
b: scaling exponent; 95% CI: 95% confidence interval for b. Averaged exponents are highlighted 
in  old. Δ  indicated difference in exponents  etween CF and C N groups.  
 
 
  CF CON  COMBINED 
OUES measure Body size variable b 95% CI b 95% CI Δb b 95% CI 
50% pea  V  2 Stature (cm) 2.77 1.19 - 4.36 4.17 3.23 - 5.10 1.40 3.60 2.72 - 4.47 
 Body Mass (kg) 1.06 0.62 - 1.51 1.06 0.61 - 1.51 0.00 1.06 0.75 - 1.37 
 BSA (m
2
) 1.63 0.94 - 2.33 1.78 1.14 - 2.42 0.15 1.72 1.26 - 2.17 
75% pea  V  2 Stature (cm) 2.17 1.26 - 3.08 3.56 2.74 - 4.37 1.39 2.93 2.31 - 3.55 
 Body Mass (kg) 0.68 0.42 - 0.95 0.91 0.55 - 1.27 0.23 0.80 0.58 - 1.02 
 BSA (m
2
) 1.09 0.68 - 1.49 1.52 1.00 - 2.04 0.43 1.31 0.98 - 1.64 
Pea  V  2 Stature (cm) 1.88 0.87 - 2.89 3.17 2.41 - 3.92 1.29 2.59 1.96 - 3.21 
 Body Mass (kg) 0.66 0.39 - 0.94 0.88 0.57 - 1.18 0.22 0.77 0.57 - 0.98 
 BSA (m
2
) 1.03 0.60 - 1.47 1.44 1.00 - 1.88 0.41 1.24 0.94 - 1.55 
AVERAGE Stature (cm) 2.23 1.54 - 2.91 3.62 3.11 – 4.12 1.39 3.00 2.58 - 3.43 
 Body Mass (kg) 0.78 0.58 - 0.97 0.94 0.72 - 1.15 0.16 0.86 0.72 – 1.01 
 BSA (m
2
) 1.21 0.91 - 1.51 1.57 1.26 - 1.88 0.36 1.40 1.18 - 1.62 
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